According to our research report, the size of the Biopsy Devices Market in the Asia Pacific was worth $321.82 million in 2019 and estimated to be growing at a CAGR of 8.54%, to reach $484.8 million by 2024.
The Asia Pacific is estimated to represent strong potential market growth in the biopsy devices market due to fast technological advancements.
A biopsy involves the removal of cells or tissues from tumors located in different parts of the body and the devices used for this process are called biopsy devices. The market is regarded as rapid innovation and technological developments, leading to continuous product improvement ensuring better patient comfort and minor trauma during and after surgery.
The market is anticipated to record growth largely because of the quickly aging population and a parallel increase in the incidence of cancer. Competitive pricing of products and reimbursement for biopsy procedures will lead to a higher uptake of biopsy devices, thereby driving the growth of the market.
The high cost of biopsy devices is likely to hamper the growth of the market.
This research report has been segmented & sub-segmented into the following categories:
Regionally, China is dominating the market and India is estimated to grow at the highest CAGR in the forecast period due to the rising aging population.
Major companies operating in the APAC Biopsy Devices Market profiled in this report are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Manual
5.1.2.2 Automated
5.1.2.3 Semi-Automated
5.1.3 Consumables
5.1.3.1 Reagents
5.1.3.2 Kits
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Needle Biopsy
5.2.2.1 Core Needle Biopsy
5.2.2.2 Fine Needle Biopsy
5.2.2.3 Vacuum-Assisted Biopsy
5.2.3 Surgical Biopsy
5.2.3.1 Incisional Biopsy
5.2.3.2 Excisional Biopsy
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Scientific Research
5.3.3 Medical Diagnosis
5.3.4 Agricultural Applications
5.3.5 Genetic fingerprinting & Sex Determination
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End Users
5.4.1 Introduction
5.4.2 Pharmaceutical and Biotechnology Industry
5.4.3 Academic Research Institute
5.4.4 Contract Research Organizations
5.4.5 Forensic Labs
5.4.6 Y-o-Y Growth Analysis, By End Users
5.4.7 Market Attractiveness Analysis, By End Users
5.4.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Leica Biosystems
8.3 Hologic Inc.
8.4 Boston Scientific Corporation
8.5 Becton
8.6 Cook Medical Inc.
8.7 C.R. Bard Inc.
8.8 Mauna Kea Technologies
8.9 Ethicon EndoSurgery Inc.
8.10 Veran Medical Technologies
8.11 Dickinson and Company
8.12 Fujifilm Medical Systems
8.13 MDxHealth
8.14 Argon Medical Devices Inc
8.15 Intact Medical Corp
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
